Buscar

Estamos realizando la búsqueda. Por favor, espere...

 Detalle_Publicacion

Risk factors for nontuberculous mycobacteria infections in solid organ transplant recipients: a multinational case-control study

Abstract: Background: Risk factors for nontuberculous mycobacteria (NTM) infections after solid organ transplant (SOT) are not well characterized. Here we aimed to describe these factors. Methods. Retrospective, multinational, 1:2 matched case-control study that included SOT recipients ?12 years old diagnosed with NTM infection from 1 January 2008 to 31 December 2018. Controls were matched on transplanted organ, NTM treatment center, and post-transplant survival greater than or equal to the time to NTM diagnosis. Logistic regression on matched pairs was used to assess associations between risk factors and NTM infections. Results: Analyses included 85 cases and 169 controls (59% male, 88% White, median age at time of SOT of 54 years [interquartile range {IQR} 40?62]). NTM infection occurred in kidney (42%), lung (35%), heart and liver (11% each), and pancreas transplant recipients (1%). Median time from transplant to infection was 21.6 months (IQR 5.3?55.2). Most underlying comorbidities were evenly distributed between groups; however, cases were older at the time of NTM diagnosis, more frequently on systemic corticosteroids and had a lower lymphocyte count (all P<.05). In the multivariable model, older age at transplant (adjusted odds ratio [aOR] 1.04; 95 confidence interval [CI], 1.01?1.07), hospital admission within 90 days (aOR, 3.14; 95% CI, 1.41?6.98), receipt of antifungals (aOR, 5.35; 95% CI, 1.7?16.91), and lymphocyte-specific antibodies (aOR, 7.73; 95% CI, 1.07?56.14), were associated with NTM infection. Conclusions: Risk of NTM infection in SOT recipients was associated with older age at SOT, prior hospital admission, receipt of antifungals or lymphocyte-specific antibodies. NTM infection should be considered in SOT patients with these risk factors.

 Autoría: Carlos Mejia-Chew, Peggy L. Carver, Sasinuch Rutjanawech, Luis F. Aranha Camargo, Ruan Fernandes, Sara Belga, Shay-Anne Daniels, Nicolas J. Müller, Sara Burkhard, Nicole M. Theodoropoulos, Douwe F. Postma, Pleun J. van Duijn, María Carmen Fariñas, Claudia González-Rico, Jonathan Hand, Adam Lowe, Marta Bodro, Elisa Vanino, Ana Fernández Cruz, Antonio Ramos, Mateja Jankovic Makek, Ribal Bou Mjahed, Oriol Manuel, Nassim Kamar, Antonia Calvo-Cano, Laura Rueda Carrasco, Patricia Muñoz, Sara Rodríguez, Sandra Pérez-Recio, Núria Sabé, Regino Rodríguez Álvarez, José Tiago Silva, Alessandra Mularoni, Elisa Vidal,Juana Alonso-Titos, Teresa del Rosal, Annika Y. Classen, Charles W. Goss, Mansi Agarwal, and Francisco López-Medrano; on behalf of the EMOTE study group

 Fuente: Clinical Infectious Diseases, 2023, 76(3), e995-e1003

Editorial: Oxford University Press

 Año de publicación: 2023

Nº de páginas: 9

Tipo de publicación: Artículo de Revista

 DOI: 10.1093/cid/ciac608

ISSN: 1058-4838,1537-6591

Url de la publicación: https://doi.org/10.1093/cid/ciac608

Autoría

MEJIA-CHEW, CARLOS

CARVER, PEGGY L.

RUTJANAWECH, SASINUCH

ARANHA CAMARGO, LUIS F.

FERNANDES, RUAN

BELGA, SARA

DANIELS, SHAY-ANNE

NICOLAS J. MÜLLER

BURKHARD, SARA

THEODOROPOULOS, NICOLE M.

POSTMA, DOUWE F.

VAN DUIJN, PLEUN J.

CLAUDIA GONZALEZ RICO

HAND, JONATHAN

LOWE, ADAM

BODRO, MARTA

VANINO, ELISA

FERNÁNDEZ CRUZ, ANA

RAMOS, ANTONIO